Abstract
In this issue, Palmer and colleagues' meta-analysis confirms earlier findings of harms associated with ESAs in patients with CKD. Remaining questions include whether there is a lower hemoglobin lim...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
